How lateral flow testing can mitigate the spread of other infectious diseases
Mark Philpott, Chief Executive of NPH Group, explains how the AI technology NPH Group used in lateral flow testing during the Covid-19 pandemic is now being considered by several governments worldwide to help reduce the spread of infectious diseases such as tuberculosis, influenza and HIV… When the COVID-19 pandemic hit the UK in 2020, we … Read more
